A study of patients with chemotherapy-related peripheral neuropathy showed 59% of those who took the antidepressant drug Cymbalta reported some pain relief, while 38% of those in the placebo group saw improvement. The results were published in the Journal of the American Medical Association.
Cymbalta eases chemo-linked pain, study finds
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||